Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if DWTX is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
1 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
15 filers reported a long position in DWTX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | $5M | 3.1M | -4.5% |
| MILLENNIUM MANAGEMENT LLC | $550.3K | 341.8K | New |
| VANGUARD CAPITAL MANAGEMENT LLC | $212.8K | 132.2K | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC | $142.2K | 88.3K | +11.2% |
| VANGUARD FIDUCIARY TRUST CO | $101K | 62.7K | Unchanged |
| BlackRock, Inc. | $46K | 28.5K | +95,053.3% |
| NORTHERN TRUST CORP | $38.3K | 23.8K | Unchanged |
| CITADEL ADVISORS LLC | $18.9K | 11.7K | New |
| Tower Research Capital LLC (TRC) | $5K | 3.1K | -61.7% |
| MORGAN STANLEY | $3.6K | 2.2K | New |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.